Side-by-side financials for FATE and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FATE | BNTX |
|---|---|---|
| Market cap | - | $22.90 B |
| US-listed rank | - | #572 |
| Revenue (latest FY) | $6.65M | - |
| Net income (latest FY) | -$136.31M | - |
| Net margin | -2051.1% | - |
| SEC filings | 827 | 548 |
Full pages: FATE THERAPEUTICS INC and BioNTech SE, or browse the full rankings.